lamivudine/zidovudine

also known as 3TC/AZT

Developed for: HIV infectious disease
Investigated by: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · National Institute of Allergy and Infectious Diseases (NIAID) · PENTA Foundation

today NCT00039741 · Ph 2/3

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2/3	NCT00039741	Aug 2002 → Aug 2009	HIV infectious disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Missed primary

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	lamivudine/zidovudine	“lamivudine/zidovudine (3TC/AZT)” NCT00039741 ↗
Known as	3TC/AZT	“lamivudine/zidovudine (3TC/AZT)” NCT00039741 ↗